The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effect of adding a selective FAK inhibitor AMP945 to FOLFIRINOX in a model of pancreatic cancer.
 
Christopher Burns
Employment - Amplia Therapeutics
Stock and Other Ownership Interests - Amplia Therapeutics; MycRx; Patrys
Consulting or Advisory Role - Cincera Therapeutics; Gate Bioscience
Patents, Royalties, Other Intellectual Property - Amplia Therapeutics; Certa Therapeutics; OccuRx
 
Kendelle Murphy
Stock and Other Ownership Interests - CSL Limited
Honoraria - Amplia Therapeutics
Patents, Royalties, Other Intellectual Property - Amplia Therapeutics
 
Terrie-Anne Cock
Employment - Amplia Therapeutics; Microbia
Stock and Other Ownership Interests - GlaxoSmithKline; Microbia; Pharmaxis
Patents, Royalties, Other Intellectual Property - Amplia Therapeutics; Microbia; Uniquest
 
Mark Devlin
Employment - Aculeus Therapeutics; Amplia Therapeutics
Stock and Other Ownership Interests - Amplia Therapeutics
Consulting or Advisory Role - Amplia Therapeutics
 
David Herrmann
Honoraria - Amplia Therapeutics
Patents, Royalties, Other Intellectual Property - Amplia Therapeutics
 
Paul Timpson
Honoraria - Amplia Therapeutics
Consulting or Advisory Role - Amplia Therapeutics
Research Funding - Amplia Therapeutics
Patents, Royalties, Other Intellectual Property - Amplia Therapeutics